Brief: Neuropace Completes Enrollment In Feasibility Study Of Rns System
03/12/2024 22:46
Dec 3 (Reuters) - Neuropace Inc NPCE.O :
* NEUROPACE COMPLETES ENROLLMENT IN FEASIBILITY STUDY OF RNS
SYSTEM FOR LENNOX-GASTAUT SYNDROME
Source text: ID:nGNX3SwRrV
Further company coverage: NPCE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuroPace
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
NeuroPace, Inc. reports results for the quarter ended June 30 - Earnings Summary
NeuroPace Q2 revenue slightly beats estimates
Brief: NeuroPace, Inc. Q2 EPS USD -0.18
NeuroPace, Inc. expected to post a loss of 21 cents a share - Earnings Preview